In defence of polypharmacy

British Journal of Clinical Pharmacology

Volumn 57, Issue 2, 2004, Pages 119-120

  Aronson, J K ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIRETROVIRUS AGENT; CYTOCHROME P450; DIURETIC AGENT; FOLIC ACID; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; DRUG EFFECT; DRUG HALF LIFE; DRUG MEGADOSE; DRUG RESEARCH; DRUG TOLERANCE; EDITORIAL; HALLUCINATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HYPONATREMIA; LOW DRUG DOSE; MALARIA; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RISK REDUCTION; SIDE EFFECT; TREATMENT WITHDRAWAL; TUBERCULOSIS;

DRUG INTERACTIONS; DRUG RESISTANCE; HUMANS; PHARMACEUTICAL PREPARATIONS; POLYPHARMACY; TREATMENT OUTCOME;

EID: 1242329172     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02067.x     Document Type: Editorial

References (6)

1. Watson G. Theriac and Mithridatium. A Study in Therapeutics. London: Wellcome Historical Medical Library 1966.
2. Aronson JK. An Account of the Foxglove and its Medical Uses, 1785-1985. Oxford: Oxford University Press 1985: 268.
3. Standl E, Fuchtenbusch M. The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus. Diabetologia 2003; 46(Suppl 1): M30-6.
4. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. Br Med J 2003; 326: 1419-23.
5. Movig KL, Leufkens HG, Lenderink AW, Van den Akker VG, Hodiamont PP, Goldschmidt HM, Egberts AC. Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol 2002; 53: 363-9.
6. Heeley E, Wilton LV, Shakir SA. Automated signal generation in prescription-event monitoring. Drug Saf 2002; 25: 423-32.